A priced round makes sense when a company and its investors are ready to negotiate an equity price and rights package, and the financing’s benefits justify the additional work. A venture round generally issues preferred stock at an agreed price, with any necessary charter changes and approvals. Outstanding SAFEs convert when their terms are triggered. Another SAFE may still fit on manageable terms. A startup lawyer can compare both paths before the company accepts a term sheet.

What is a priced round?
A priced round is an equity financing at an agreed share price. In venture financings, investors generally purchase preferred stock. This article focuses on Delaware corporations. The price depends on the negotiated valuation and capitalization definition, including how converting instruments and any option-pool increase are treated. A headline pre-money valuation alone does not resolve that calculation.
Many startups need an amended and restated charter to establish the preferred rights and sufficient authorized shares. But Delaware Section 151 also permits a board to establish series terms and file a certificate of designations when the existing charter expressly delegates the necessary authority. An existing series may already meet the financing’s needs.
When a charter amendment is required, Section 242 generally requires board action and the applicable stockholder approval, which may include separate class or series votes and greater charter thresholds. Section 228 permits written consent unless the charter provides otherwise, with applicable voting and notice requirements. Our guide to board and stockholder consents explains the approval process.
The NVCA model legal documents provide a coordinated starting point with selectable terms. The purchase agreement addresses the shares, price, representations and closing conditions. The charter establishes preferred rights. An investors’ rights agreement addresses reporting, future investment access and registration rights. Voting and transfer agreements address board arrangements, sale obligations and covered stock transfers. The package is tailored to the deal, not adopted unchanged as a legal requirement.
A priced seed can use a narrower package than a later financing. Its suitability depends on the investment, negotiated rights and execution burden, not the company’s stage alone.
How is a priced round different from raising on SAFEs?
Our SAFE versus convertible note guide explains those instruments. Here, the question is whether to issue equity now.
| Feature | SAFE financing | Priced equity financing |
|---|---|---|
| Valuation | Contractual cap, discount or other conversion terms. Not entirely unpriced | Agreed share price using a defined capitalization basis |
| Investor receives | Contractual conversion and other rights under the instrument | Equity issued under the closing terms |
| Charter | Review existing authority and obligations | Amendment or designation may be needed. Existing terms may suffice |
| Governance | Depends on existing arrangements and negotiated rights | Negotiated stockholder and governance package |
| Documents | SAFE, applicable side letters and approvals | Tailored purchase, charter and investor agreements with approvals |
| Dilution visibility | Model from each instrument. Capped post-money estimates have limits | Reconciled closing capitalization, still subject to future dilution |
| Cost and timing | Depends on scope, records and negotiation | Often more documentation and negotiation, not a fixed timetable |
| Securities compliance | Applicable exemption or registration and related requirements | Assess exemption, new offering versus continuation, and filings |
Illustrative comparison for venture financing. The actual instruments, governing documents, approvals and offering exemption control.
How do outstanding SAFEs convert in a priced round?
Conversion depends on each instrument’s terms. YC’s capped post-money SAFE converts at the initial closing of a qualifying Equity Financing before termination into whichever contractual alternative produces more shares. One uses the lowest new-money share price for Standard Preferred Stock. The other uses the cap-derived Safe Price for Safe Preferred Stock. The cap does not always control.
Safe Preferred Stock, often called shadow preferred, has the same model rights and liquidation multiple as Standard Preferred Stock, except for price-based preferences. Its per-share liquidation amount, initial conversion price and per-share dividend amount are based on the applicable SAFE price. A holder may instead receive Standard Preferred Stock, so three different caps do not inevitably require three shadow series.
Discount-only SAFEs use their discount formula, while MFN instruments and amendments require separate review. Any outstanding notes also need analysis of interest, maturity and financing thresholds under their convertible note terms. The model should identify which instruments actually convert at the proposed closing.
The YC User Guide estimates capped post-money SAFE ownership by dividing each purchase amount by its own cap. For example, $1.5 million at a $10 million cap gives a 15% estimate, while another $1.5 million at a $20 million cap gives 7.5%. Together they estimate 22.5%, not the 20% obtained by dividing $3 million by a simple $15 million average cap.
That illustration assumes the cap-based results control and measures ownership before the new financing money and its related pool increase. A financing valuation below or close to a cap can produce more shares than the estimate. Under the standard post-money framework, a financing-related pool increase can dilute converting SAFE holders as well as founders. The actual capitalization definitions matter.
The company’s model should reconcile instruments, existing equity, participation rights, the proposed pool and new money. Closing establishes a capitalization snapshot, not immunity from later dilution. Pricing a round does not reverse the ownership already sold.
Each side letter also needs a disposition at closing. It may terminate, continue, be waived or be replaced under the necessary consents. Participation rights can affect the allocation offered to new investors. Our SAFE side-letter guide explains those mechanics. A new investors’ rights agreement does not automatically erase every letter or make every converting investor eligible for the same rights.
When is it time to price a round?
No statutory fundraising threshold decides the question. These considerations help compare the benefits and burdens.
-
An investor is ready to negotiate equity terms. A preferred-stock proposal can provide a workable basis for pricing. The relevant question is whether its capital, rights and closing conditions suit the company, not simply whether an institutional investor made it.
-
The funding need supports the transaction. The company can compare expected runway and financing certainty against documentation, diligence and negotiation costs. Total SAFE proceeds alone do not establish that another SAFE is inappropriate.
-
The instruments have become harder to model. Different caps and amendments can complicate conversion. A higher cap on the same investment amount reduces its cap-based ownership estimate, but cumulative fundraising still matters. Prior caps do not dictate the next investor’s valuation.
-
The company wants a coordinated rights package. Board arrangements, reporting and consent rights can be negotiated with a priced financing. Some can also exist alongside SAFEs, so governance needs call for a structural comparison rather than an automatic switch.
-
Equity compensation needs updated analysis. A financing provides information relevant to common-stock value. Under the valuation rules, material information must be reflected when assessing later grant-date pricing. The preferred price does not mechanically reset common-stock value. Our option-pool and 409A guide explains when existing valuation work remains usable.
-
The ownership outcome no longer fits the plan. Comparing another SAFE with a priced proposal can expose the trade-offs. The company may also reconsider the amount sought, timing or terms. A priced round is not itself a cure for excessive dilution.
Another SAFE can remain useful for a bounded bridge or an investment that does not justify a broader equity negotiation, provided the company can model and perform its commitments. Conversely, a small priced investment may be worthwhile on suitable terms. Neither check size nor investor preference alone settles the decision.
What terms do founders negotiate in a priced round?
The NVCA models illustrate how economics and control are allocated through different provisions. Founders benefit from reviewing the package rather than trading everything for a higher headline valuation.
-
Liquidation preference. A one-times, nonparticipating structure generally gives the holder a preference based on its investment or the as-converted outcome, not both. Available proceeds, seniority, dividends and conversion terms affect the result. Participating preferred adds participation in remaining proceeds, subject to any cap and the negotiated language.
-
Anti-dilution protection. These provisions adjust conversion terms for covered lower-priced issuances. A weighted-average formula considers price and issuance size. Full-ratchet protection generally adjusts to the lower price without the same weighting. Exceptions and definitions determine how either operates.
-
Protective provisions. These identify actions needing specified consent, potentially including senior securities, a sale or charter changes. Thresholds, exceptions and scope determine the practical constraint on operations.
-
Board composition. Seat numbers, designation rights, vacancies and removal provisions are negotiated. The voting agreement and charter need to work together. An investor seat is not an automatic consequence of every priced financing.
-
Option pool. The size should reflect the hiring plan. Whether an increase is included in the negotiated pre-money capitalization affects who bears dilution.
-
Drag-along and co-sale. A drag-along binds participating or otherwise bound holders under agreed approvals and safeguards, not every minority holder automatically. Co-sale provisions cover defined transfers by specified holders, subject to exceptions. Both require attention to the actual scope.
-
Investor counsel fees. Reimbursement is a negotiated allocation of expense. Any cap, covered work and payment conditions should be clear rather than assumed.
What does the priced round require from the company?
The financing needs an available registration exemption or registration. Rule 503 requires a Form D for each new offering relying on Rule 504 or 506 and sets amendment requirements for continuing offerings. Whether related sales belong together requires analysis of the offering facts and Rule 152’s integration framework, not just the instrument’s label.
The SEC’s Form D guidance places the initial deadline fifteen calendar days after the first investor becomes irrevocably contractually committed, which may precede payment. Rule 503 moves a weekend or holiday deadline to the next business day. Late filing does not automatically defeat a Rule 506 exemption. Applicable state requirements also need review. Our Regulation D guide covers the framework.
Diligence commonly includes the capitalization table, signed instruments, required approvals, founder stock records, applicable 83(b) elections, IP assignments, equity-plan records, valuation work, side letters and material contracts. Missing records can delay closing, but organized files do not guarantee a timetable. Closing conditions, negotiations and funding arrangements also matter.
Tax records should distinguish shares issued for new money from converting instruments. Section 1202 includes holding-period carryover for certain qualifying stock conversions but does not resolve every SAFE’s tax classification. The financing date alone does not answer every investor’s holding-period question. Our QSBS eligibility guide addresses the separate tests.
Mistakes that recur
-
Using a fundraising threshold as the decision rule. The amount raised matters in context, not as proof that either instrument is now mandatory.
-
Accepting valuation without the conversion model. A headline number does not reveal the combined effect of outstanding instruments, pool changes and new investment.
-
Assuming one structure is always cheaper. Scope, records and negotiation can change the cost of either path. A proposal should define the work.
-
Ignoring the exit economics. Liquidation and anti-dilution terms can materially change outcomes even when the headline valuation looks attractive.
-
Forgetting side letters. Participation, MFN and consent obligations should be identified before allocation and closing terms are promised.
-
Treating closing as the end of compliance. Offering notices, amendments, state obligations and support for later option pricing need assigned responsibility.
When to involve a lawyer
Counsel is most useful before the company commits to a term sheet. The work can include instrument reconciliation, conversion modeling with the finance team, approvals, diligence and definitive agreements. Defined projects may be quoted at a fixed fee. Ongoing counsel may be provided under a scoped monthly retainer, with financing work separately addressed in a written proposal. Founders can contact Omni Law P.C. to discuss the proposed financing and existing commitments.
Frequently asked questions
What is a priced round?
A priced round is an equity financing at an agreed share price, generally involving preferred stock in venture deals. Rights, capitalization and approvals are negotiated and documented. Whether a new series or charter amendment is needed depends on existing authority and the proposed terms.
What is the difference between a SAFE and a priced round?
A priced round issues equity at an agreed price. A SAFE establishes contractual conversion and other rights without issuing the financing shares immediately. A capped post-money SAFE can provide an ownership estimate, so its economics are not entirely deferred or unknowable.
When should a startup do a priced round instead of a SAFE?
When the expected funding and negotiated equity package justify the additional work compared with another SAFE. Investor requirements, runway, existing commitments and modeled ownership are useful inputs. There is no universal fundraising threshold or two-signal rule.
What happens to SAFEs in a priced round?
SAFEs convert when their applicable financing terms are triggered. YC’s capped form can produce Standard Preferred Stock or Safe Preferred Stock, depending on which alternative yields more shares. Discount-only, MFN and modified instruments need their own analysis.
What is shadow preferred stock?
Shadow preferred is a separate series used for certain converting investments. Under YC’s model, it preserves the new-money series’ rights and liquidation multiple while adjusting price-based preferences to the SAFE price. Different caps do not inevitably require different shadow series.
What approvals does a priced round need under Delaware law?
The company needs the applicable corporate authorization for the financing and issuance. A Section 242 amendment can require stockholder and separate class or series approvals. Existing board authority under Section 151 may permit a designation instead. Charter terms and contractual consents also matter.
What is a liquidation preference?
A liquidation preference gives preferred holders a contractual priority in covered distributions. Nonparticipating preferred generally receives its preference or the as-converted outcome, while participating terms can add a share of remaining proceeds. Available proceeds, seniority and the signed terms determine the result.
Does a priced round require a new Form D?
A new and distinct Regulation D offering needs its own Form D. A continuing offering may instead require an amendment. Counsel should determine the applicable treatment, initial sale date and state obligations rather than relying only on the financing’s label.
How long does a priced round take?
Timing depends on records, approvals, negotiation and closing conditions. Organized documents can reduce avoidable delays, but no fixed number of weeks applies to every round. The parties should agree on a realistic process before relying on a funding date.
Can a startup do a priced seed round?
Yes. A seed financing can issue equity at an agreed price with a tailored rights package. The choice depends on funding needs, terms and execution burden, not a requirement to use SAFEs until a later stage.
Model the stack before the term sheet
If you are evaluating a priced financing or another SAFE, contact Omni Law P.C. to request a consultation. Do not send confidential or time-sensitive information. Contacting the firm does not create an attorney-client relationship. Representation begins only if Omni Law P.C. agrees in writing to undertake the matter.
Last reviewed November 4, 2026
Attorney Advertising. This page provides general information, not legal advice. Reading it or contacting Omni Law P.C. does not create an attorney-client relationship. Do not send confidential or time-sensitive information unless the firm has agreed in writing to represent you. Prior results do not guarantee a similar outcome. Financing terms described as standard or typical are common practice and not legal requirements. Statutes and forms cited are current as of the review date and may change. Obtain advice about your circumstances before acting.